|
gptkbp:instance_of
|
gptkb:virus
|
|
gptkbp:bfsLayer
|
3
|
|
gptkbp:bfsParent
|
gptkb:Athenex
gptkb:temple
gptkb:Guillain-Barré_syndrome
gptkb:Nant_Kwest,_Inc.
gptkb:healthcare_organization
gptkb:Company
gptkb:smartphone
gptkb:Pfizer
gptkb:poliomyelitis
gptkb:Insurance_Company
gptkb:Cure_Vac
gptkb:Nant_Kwest
gptkb:castle
gptkb:drug
gptkb:currency
gptkb:classic_seminoma
|
|
gptkbp:caused_by
|
gptkb:poliomyelitis
|
|
gptkbp:community_impact
|
endemic in some regions
outbreaks reported
|
|
gptkbp:complications
|
respiratory failure
muscle atrophy
scoliosis
joint deformities
post-polio syndrome
|
|
gptkbp:family
|
gptkb:Picornaviridae
|
|
gptkbp:first_introduced
|
1928
|
|
gptkbp:genetic_diversity
|
three
Lansing strain
Mahoney strain
|
|
gptkbp:genus
|
gptkb:virus
|
|
gptkbp:healthcare
|
gptkb:battle
|
|
gptkbp:historical_impact
|
major epidemics in the 20th century
significant public health campaigns
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
vaccine
|
|
https://www.w3.org/2000/01/rdf-schema#subClassOf
|
gptkb:vaccines
|
|
gptkbp:is_affected_by
|
gptkb:Person
|
|
gptkbp:is_monitored_by
|
environmental sampling
acute flaccid paralysis monitoring
|
|
gptkbp:is_protected_by
|
vaccination
|
|
gptkbp:is_vulnerable_to
|
gptkb:Albert_Bruce_Sabin
gptkb:inactivated_polio_vaccine
gptkb:Jonas_Salk
logistical issues
vaccine hesitancy
long-lasting immunity
oral polio vaccine
high efficacy
high in developed countries
access in remote areas
low in some developing countries
|
|
gptkbp:iso639-3
|
Leon strain
|
|
gptkbp:research_focus
|
genetic studies
vaccine development
treatment options
pathogenesis
|
|
gptkbp:seed_dispersal
|
single-stranded RNA
|
|
gptkbp:social_responsibility
|
PCR
Coxsackievirus
Echovirus
viral culture
linked to vaccine-derived strains
|
|
gptkbp:status
|
near eradication
|
|
gptkbp:successor
|
public health emergency
|
|
gptkbp:symptoms
|
fatigue
headache
fever
muscle weakness
paralysis
|
|
gptkbp:transmission
|
fecal-oral route
|
|
gptkbp:treatment
|
supportive care
rehabilitation strategies
antiviral drugs
immune therapies
|
|
gptkbp:type
|
non-enveloped
|
|
gptkbp:year_created
|
1909
|